#5629 on the rich list of 14,644 insiders
Beth Hecht
See Remarks at Xeris Biopharma Holdings. Based in Chicago, Illinois.
$18.0M
in disclosed stock, −$445K (−2.41%) today
Live prices, last trade 3:24 PM ET
- Rank
- 5629th of 14,644
- Companies held
- 1
- Largest holding
- XERS, 100.0% of total
- Latest SEC filing
- Nov 2, 2026
What the $18.0M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Xeris Biopharma Holdings XERS Common Stock | Directly | 1,086,130 | $16.58 | $18.0M | 100.0% | Form 4, Nov 2, 2026 |
Share counts are the amounts Beth Hecht reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
| Date | Trade | Company | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Nov 2, 2026 | Sold | XERS | 25,000 | $10.23 | $256K | View |
| Oct 1, 2026 | Sold | XERS | 16,666 | $9.41 | $157K | View |
| Sep 1, 2026 | Sold | XERS | 16,666 | $8.49 | $141K | View |
| Aug 3, 2026 | Sold | XERS | 16,666 | $8.01 | $133K | View |
| Jul 1, 2026 | Sold | XERS | 16,666 | $8.03 | $134K | View |
| Jun 1, 2026 | Sold | XERS | 16,667 | $6.06 | $101K | View |
| May 1, 2026 | Sold | XERS | 16,667 | $6.23 | $104K | View |
| Apr 1, 2026 | Sold | XERS | 16,667 | $5.99 | $100K | View |
| Mar 2, 2026 | Sold | XERS | 16,567 | $6.24 | $103K | View |
| Mar 2, 2026 | Sold | XERS | 100 | $7.06 | $706 | View |
| Feb 2, 2026 | Sold | XERS | 16,667 | $7.45 | $124K | View |
| Jan 2, 2026 | Sold | XERS | 16,667 | $7.43 | $124K | View |
| Dec 1, 2025 | Sold | XERS | 16,667 | $7.01 | $117K | View |
| Nov 11, 2025 | Sold | XERS | 16,667 | $7.40 | $123K | View |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 5626 | Yujiro Hata President and CEO, IDEAYA Biosciences. South San Francisco, CA | $18.0M |
| 5627 | Donald Thompson Director, Royal Caribbean Cruises. Chicago, IL | $18.0M |
| 5628 | John A. Olin Executive Vice President & CFO, Westinghouse Air Brake Technologies. Bonita Springs, FL | $18.0M |
| 5629 | Beth Hecht See Remarks, Xeris Biopharma Holdings. Chicago, IL | $18.0M |
| 5630 | Bryce Blair Director, PulteGroup. Atlanta, GA | $18.0M |
| 5631 | Jeffrey L. Ritenour EVP & CHIEF CORP DEV OFFICER, Devon Energy. Houston, TX | $18.0M |
| 5632 | Sheldon Hall Senior Advisor to CEO, Capital One Financial. Mclean, VA | $18.0M |
Other Xeris Biopharma Holdings insiders
All XERS insiders- Paul R. Edick$63.4MSee Remarks. #2155 overall
- John Patrick Shannon Jr.$48.1MSee Remarks. #2625 overall
- Kevin McCulloch$26.3MSee Remarks. #4213 overall
- Steven Pieper$22.3MSee Remarks. #4777 overall
- Steven Prestrelski$11.9MChief Scientific Officer. #7708 overall
- John Johnson$11.7MDirector. #7276 overall
Questions
How much stock does Beth Hecht own?
Beth Hecht holds $18,008,035 in listed stock based on SEC filings and current prices, mostly Xeris Biopharma Holdings (XERS). That ranks 5629th on the Stock Rich List.
Is this Beth Hecht's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Beth Hecht last buy or sell stock?
The most recent open-market trade on file is a sale of 25,000 XERS shares on Nov 2, 2026 at $10.23.